Who owns CENTURY THERAPEUTICS INC?
- Ticker: IPSC
- CUSIP Number: 15673t100
Tip: Access positions for across all investors
Analyze quarterly positions in Century Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Century Therapeutics stock
Who bought or sold CENTURY THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 18M | $40M | 100% | Mar 2026 |
|
| TCG Crossover Management | 18M | $39M | 100% | Mar 2026 |
|
| Versant Venture Management | 12M | $28M | 100% | Mar 2026 |
|
| Deep Track Capital | 9.5M | $21M | 100% | Mar 2026 |
|
| Commodore Capital | 8.7M | $20M | 100% | Mar 2026 |
|
| VR Adviser | 8.7M | $20M | 100% | Mar 2026 |
|
| Point72 Asset Management | 6.0M | $14M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 5.7M | $13M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 5.0M | $11M | 100% | Mar 2026 |
|
| Millennium Management | 4.7M | $11M | 665% | Mar 2026 |
|
| Woodline Partners | 3.0M | $6.9M | 100% | Mar 2026 |
|
| Seven Fleet Capital Management | 2.9M | $6.7M | 100% | Mar 2026 |
|
| Trails Edge Capital Partners | 2.4M | $5.5M | 100% | Mar 2026 |
|
| DAFNA Capital Management | 2.4M | $5.5M | -13% | Mar 2026 |
|
| Two Sigma Investments | 2.4M | $5.4M | 59% | Mar 2026 |
|
| Vanguard Group | 2.1M | $2.1M | 0% | Dec 2025 |
|
| Adage Capital Partners GP | 1.8M | $1.8M | 100% | Dec 2025 |
|
| BlackRock | 1.5M | $3.4M | 153% | Mar 2026 |
|
| DV Trading | 1.4M | $3.2M | 100% | Mar 2026 |
|
| Renaissance Technologies | 1.3M | $1.3M | -48% | Dec 2025 |
|
| Rock Springs Capital Management | 1.3M | $2.9M | 100% | Mar 2026 |
|
| Geode Capital Management | 1.3M | $2.9M | 185% | Mar 2026 |
|
| Casdin Capital | 1.2M | $2.8M | 0% | Mar 2026 |
|
| Syncona Portfolio | 1.2M | $2.7M | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 693k | $1.6M | 100% | Mar 2026 |
|
| Superstring Capital Management | 463k | $461k | 0% | Dec 2025 |
|
| Acadian Asset Management | 278k | $627k | -77% | Mar 2026 |
|
| Goldman Sachs Group | 211k | $476k | 100% | Mar 2026 |
|
| Bank of America Corporation | 145k | $328k | 100% | Mar 2026 |
|
| State Street Corporation | 127k | $127k | 0% | Dec 2025 |
|
| Squarepoint Ops | 120k | $270k | 100% | Mar 2026 |
|
| Northern Trust | 105k | $105k | 57% | Dec 2025 |
|
| Brevan Howard Capital Management | 97k | $218k | 100% | Mar 2026 |
|
| Raymond James Financial | 91k | $91k | 0% | Dec 2025 |
|
| GSA Capital Partners | 77k | $174k | -77% | Mar 2026 |
|
| FMR | 72k | $71k | -63% | Dec 2025 |
|
| Invesco | 62k | $140k | 100% | Mar 2026 |
|
| Dimensional Fund Advisors | 55k | $125k | 100% | Mar 2026 |
|
| Susquehanna International | 50k | $50k | -26% | Dec 2025 |
|
| Cannon Global Investment Management | 49k | $111k | 100% | Mar 2026 |
|
| OMERS Administration Corporation | 48k | $108k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 45k | $101k | 100% | Mar 2026 |
|
| HarbourVest Partners | 29k | $29k | 0% | Dec 2025 |
|
| Jane Street | 28k | $64k | -37% | Mar 2026 |
|
| Parametrica Management | 28k | $63k | 0% | Mar 2026 |
|
| Morgan Stanley | 26k | $59k | 100% | Mar 2026 |
|
| Prudential Financial | 25k | $57k | -58% | Mar 2026 |
|
| Quadrant Private Wealth Management | 20k | $45k | 31% | Mar 2026 |
|
| XTX Topco | 15k | $15k | -44% | Dec 2025 |
|
| UBS Group | 14k | $32k | -93% | Mar 2026 |
|
| Citadel Advisors | 13k | $30k | -96% | Mar 2026 |
|
| Bank of New York Mellon | 13k | $29k | 100% | Mar 2026 |
|
| Advisors Asset Management | 8.3k | $19k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 4.4k | $9.4k | 6089% | Mar 2026 |
|
| Farther Finance Advisors | 2.5k | $5.5k | 100% | Mar 2026 |
|
| Simplex Trading | 2.4k | $2.4k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $3.2k | -2% | Mar 2026 |
|
| SBI Securities | 1.3k | $2.8k | -18% | Mar 2026 |
|
| NISA Investment Advisors | 883.00 | $2.0k | 0% | Mar 2026 |
|
| Mark Sheptoff Financial Planning | 500.00 | $1.1k | 0% | Mar 2026 |
|
| Fortitude Family Office | 294.00 | $663.999000 | 100% | Mar 2026 |
|
| SRS Capital Advisors | 99.00 | $223.997400 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 40.00 | $90.000000 | 0% | Mar 2026 |
|
| Optiver Holding B.V. | 32.00 | $72.000000 | 0% | Mar 2026 |
|
| Smartleaf Asset Management | 1.00 | $2.000000 | 0% | Mar 2026 |
|
| Barclays | 1.00 | $1.000000 | 0% | Dec 2025 |
|
Who sold out of Century Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Advisers | Dec 2025 | 1.3M | $1.3M |
| Wealth Enhancement Advisory Services | Dec 2025 | 78k | $70k |
| Algert Coldiron Investors | Dec 2025 | 77k | $76k |
| Marshall Wace | Sep 2025 | 54k | $27k |
| Bluefin Capital Management | Sep 2025 | 24k | $12k |
| Qube Research & Technologies | Sep 2025 | 18k | $8.7k |
| Tower Research Capital | Sep 2025 | 13k | $6.5k |
| Scientech Research | Dec 2025 | 12k | $12k |
| Jpmorgan Chase & Co | Sep 2025 | 1.6k | $743.453100 |
| Advisory Services Network | Sep 2025 | 407.00 | $203.011600 |
| CWM | Sep 2025 | 254.00 | $0 |